Watch: Delving into the data of people with chronic lymphocytic leukaemia (CLL)
In this new video, we take a look into the lab at Professor Jim Allan's research, as he identifies two genes which could help predict who would benefit from early treatment of CLL.
Meet Professor Jim Allan, one of our brilliant researchers looking at genetic markers of people with chronic lymphocytic leukaemia (CLL).
He found changes in two genes that are powerful at predicting who has a more aggressive type of disease, and therefore when they might need treatment.
This understanding could help clinicians identify people who would benefit from early treatment to slow the progression of CLL.
Want to talk?
If you have questions or worries, ask a blood cancer nurse. Our specialist nurses can help you make sense of things. So you can talk to your hospital team with confidence.